Ranunculus Bulbosus Granule 1dh - 30ch 1 Dh Tablet is a Health Canada–registered human drug (DIN 00700231) held by Dolisos Laboratoires S.a., containing Ranunculus Bulbosus. Health Canada lists its status as Cancelled Post Market (status date 09 Feb 1998). Nexara Health has matched 17 registrations of Ranunculus Bulbosus across 2 other regulated markets.
Health Canada registration
| DIN | 00700231 |
|---|---|
| Brand name | Ranunculus Bulbosus Granule 1dh - 30ch |
| Active ingredient | Ranunculus Bulbosus |
| Strength | 1 Dh |
| Dosage form | Tablet |
| Route | Oral |
| Company | Dolisos Laboratoires S.a. |
| Status | Cancelled Post Market — 09 Feb 1998 |
| Class | Human |
| ATC | |
| AHFS | 92:02.00* ; See footnote |
| Regulator record | Health Canada DPD entry · Product monograph |
Ranunculus Bulbosus registered in other markets
17 registrations of the same molecule in 2 national registries outside Canada (first 10 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Netherlands | Ranunculus bulbosus | BOIRON (Messimy) | 4 DH t/m 60 DH#2 CH t/m 200 CH#6 K t/m 100.000 K#1 LM t/m 30 LM | Uitsluitend apotheek of drogist | EU national register | |
| Netherlands | Ranunculus bulbosus | BOIRON (Messimy) | 4 DH t/m 60 DH#2 CH t/m 200 CH#6 K t/m 100.000 K#1 LM t/m 30 LM | Globuli | Uitsluitend apotheek of drogist | EU national register |
| United States | Ranunculus bulbosus | Boiron | Pellet | listed | FDA NDC | |
| United States | Ranunculus bulbosus | Boiron | Pellet | listed | FDA NDC | |
| United States | Ranunculus bulbosus | Boiron | Pellet | listed | FDA NDC | |
| United States | Ranunculus bulbosus | Boiron | Pellet | listed | FDA NDC | |
| United States | Ranunculus bulbosus | Boiron | Pellet | listed | FDA NDC | |
| United States | Ranunculus bulbosus | Boiron | Pellet | listed | FDA NDC | |
| United States | Ranunculus Bulbosus | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Ranunculus Bulbosus | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC |
See every manufacturer of Ranunculus Bulbosus worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Ranunculus Bulbosus Granule 1dh - 30ch (DIN 00700231) marketed in Canada?
No. Health Canada lists DIN 00700231 as Cancelled Post Market as of 09 Feb 1998.
Who holds the Canadian licence for this product?
Dolisos Laboratoires S.a. is the company of record in the Health Canada Drug Product Database.
Is Ranunculus Bulbosus registered outside Canada?
Yes — Nexara Health has matched 17 registrations in 2 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 00700231, status date 1998-02-09; national medicine registries: EU national register, FDA NDC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 00700231, status date 1998-02-09; national medicine registries: EU national register, FDA NDC.
Health Canada Drug Product Database (DPD), DIN 00700231, status date 1998-02-09; national medicine registries: EU national register, FDA NDC. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.